Passive investing: Q&A with VolitionRX’s IRO

May 25, 2017
<p>For Scott Powell, head of IR at cancer diagnostics company VolitionRX, finding ways to communicate with passive investors is a worthwhile &ndash; if difficult-to-achieve &ndash; goal.</p>
Do you know what percentage of your investors are passive versus active? If so, has the number grown recently? Institutional investors own approximately 25 percent of our outstanding shares, with the majority – about 23 percent of that 25 percent – being active

Content Preview

to continue reading

Sign up to get stories direct to your inbox
logo-black logo-black